PIER 88 INVESTMENT PARTNERS LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
PIER 88 INVESTMENT PARTNERS LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$164,000
+290.5%
6,650
+310.5%
0.05%
+308.3%
Q2 2021$42,000
-92.3%
1,620
-90.6%
0.01%
-93.5%
Q1 2021$549,000
-42.3%
17,326
-15.4%
0.19%
-39.2%
Q4 2020$951,000
-28.7%
20,491
-49.4%
0.31%
-24.3%
Q3 2020$1,333,000
+332.8%
40,481
+260.6%
0.40%
+359.1%
Q2 2020$308,000
+12.0%
11,225
+22.1%
0.09%
-12.0%
Q1 2020$275,0009,1900.10%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders